Subst Abuse Treat Prev Policy. 2013;8:17. doi:10.1186/1747-597X-8-17PubMedGoogle ScholarCrossref 251. Shuey B, Lee D, Ugalde I, et al. Evaluation of resident physicians’ knowledge of and attitudes towards prescribing buprenorphine for patients with opioid use disorder. ...
Evaluation of the substance abuse and crime prevention Act University of California Los Angeles, Los Angeles (2005) Google Scholar Loue, 2003 S. Loue The criminalization of the addictions. Toward a unified approach The Journal of Legal Medicine, 24 (2003), pp. 281-330, 10.1080/01947640390231948...
A significant proportion of youth and young adults use cannabis products with tetrahydrocannabinol (THC) levels over 20%, a stark increase from the 3% levels seen in the 1980s [2]. THC is the main psychoactive ingredient in cannabis, and higher potencies are more harmful, especially for young...
132. Gandhi AG, Murphy-Graham E, Petrosino A, Chrismer SS, Weiss CH: The devil is in the details: Examining the evidence for "proven" school-based drug abuse prevention programs. Eval Rev 2007, 31:43-74. 133. Mark M, Weiss CH: The oral history of evaluation, part 4: The ...
An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. . J Nerv Ment Dis. 1980;168(1):26-33. PubMedGoogle ScholarCrossref 50. Folstein MF, Luria R. Reliability, validity, and clinical application of the Visual Analogue Mood Scale. . Psychol ...
(1) give a brief overview of the substance abuse crisis and then (2) examine the empirical evidence illustrating faith’s contribution to preventing people from falling victim to substance abuse and helping them recover from it. After mapping the extensive literature in this field, we will ...
Gilchrist G, Landau S, Radcliffe P, McMurran M, Feder G, Easton C, et al. A study protocol to assess the feasibility of conducting an evaluation trial of the ADVANCE integrated intervention to address both substance use and intimate partner abuse perpetration to men in substance use treatment...
Context Placebo and nocebo effects, the therapeutic and adverse effects, respectively, of inert substances or sham procedures, represent serious confounds in the evaluation of therapeutic interventions. They are also an example of cognitive processes, particularly expectations, capable of influencing ...
Burgdorf K, Layne M, Roberts T, Miles D, Herrell JM. Economic costs of residential substance abuse treatment for pregnant and parenting women and their children. Evaluation and Program Planning. 2004; 27 :233–240.Economic costs of residential substance abuse treatment for pregnant and parenting ...
For example, the level of plasma exosomal miRNAs that have been identified from HIV infection and/or heroin abuse can be used as biomarkers in immune regulation and neuroinflammation34. Furthermore, miRNAs and exosomes have been proposed as new diagnostic biomarkers for patients with anxiety35 and ...